Nanoparticle Albumin‐Bound Paclitaxel and Nivolumab for <scp>PD</scp> ‐1 Inhibitor‐Refractory Recurrent or Metastatic Head and Neck Squamous‐Cell Carcinoma Authors Christine Auberle (ORCID: https://orcid.org/0000-0002-0080-4514) Jessica Ley (ORCID: https://orcid.org/0000-0001-5092-8884) P. Oppelt Jesse M. Zaretsky (ORCID: https://orcid.org/0000-0002-4889-2648) D. Adkins Jingxia Liu (ORCID: https://orcid.org/0000-0002-9434-7907) Brendan Knapp Institutions Washington University in St. Louis (US) Jewish Hospital (US) Washington University Medical Center (US) Publication Details Journal Cancer Medicine Published 2026-01-01 DOI https://doi.org/10.1002/cam4.71533 Primary Topic Head and Neck Cancer Studies Type article Field-Weighted Citation Impact 0.00 Funders Bristol-Myers Squibb Alvin J. Siteman Cancer Center National Cancer Institute Explore the Global Research Space Interactive Map